DEMONSTRATION OF INTERLEUKIN-6 IN MIDDLE-EAR EFFUSIONS

被引:2
|
作者
YELLON, RF
LEONARD, G
MARUCHA, P
SIDMAN, J
CARPENTER, R
BURLESON, J
CARLSON, J
KREUTZER, D
机构
[1] UNIV CONNECTICUT HLTH CTR, DEPT PATHOL, FARMINGTON, CT 06030 USA
[2] STAMFORD HOSP, DEPT SURG, STAMFORD, CT 06904 USA
[3] UNIV CONNECTICUT, CTR HLTH, DEPT SURG, DIV OTOLARYNGOL, FARMINGTON, CT 06032 USA
[4] UNIV CONNECTICUT, CTR HLTH, DEPT BEHAV SCI, FARMINGTON, CT 06032 USA
关键词
D O I
暂无
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
In response to infection in the middle ear, inflammatory cells produce cytokines-potent regulators and mediators of the immune response. In an earlier study, we demonstrated that levels of the cytokine interleukin 1 were higher in middle-ear effusions from younger children, while levels of the cytokine tumor necrosis factor were higher in middle-ear effusions from older children and in those requiring tympanostomy on multiple occasions. In this study, we evaluated middle-ear effusions for levels of the cytokine interleukin 6. Activities of interleukin 6 include stimulation of bone erosion and production of antibodies and fever. Using an enzyme-linked immunosorbent assay system, significant levels of interleukin 6 (>0.2 pg/mL) were found in 14 (36%) of 39 middle-ear effusions from 25 children with otitis media with effusion. The mean (+/-SE) level of interleukin 6 in middle-ear effusions was 173.9+/-74.7 pg/mg of total protein. Like interleukin 1, levels of interleukin 6 were higher in younger children. Tumor necrosis factor may be an important regulator of the local immune response in the middle-ear cleft during persistence of otitis media with effusion, while interleukin 1 and interleukin 6 may be important regulators during the early stages of otitis media with effusion.
引用
收藏
页码:745 / 748
页数:4
相关论文
共 50 条
  • [21] HISTAMINE CONCENTRATION IN MIDDLE-EAR EFFUSIONS
    SKONER, DP
    DOYLE, WJ
    TANNER, EP
    FIREMAN, P
    PEDIATRIC RESEARCH, 1985, 19 (04) : A281 - A281
  • [22] ANTIBIOTICS AND CHRONIC MIDDLE-EAR EFFUSIONS
    MILLS, RP
    MARKS, NJ
    SHAHEEN, OH
    CLINICAL OTOLARYNGOLOGY, 1983, 8 (02): : 136 - 136
  • [23] PROSTAGLANDINS IN HUMAN MIDDLE-EAR EFFUSIONS
    JACKSON, RT
    WAITZMAN, MB
    PICKFORD, L
    NATHANSON, SE
    PROSTAGLANDINS, 1975, 10 (02): : 365 - 371
  • [24] LYSOSOMAL HYDROLASES IN MIDDLE-EAR EFFUSIONS
    DIVEN, WF
    GLEW, RH
    BLUESTONE, CD
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1981, 90 (02): : 148 - 153
  • [25] PATHOGENESIS AND PATHOPHYSIOLOGY OF MIDDLE-EAR EFFUSIONS
    HORMANN, K
    ACTA OTO-LARYNGOLOGICA, 1987, : 7 - 59
  • [26] HETEROPHILE ANTIBODIES IN MIDDLE-EAR EFFUSIONS
    BERNSTEIN, JM
    KANO, K
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1982, 108 (05) : 267 - 269
  • [27] MANAGEMENT OF MIDDLE-EAR EFFUSIONS IN CHILDREN
    HUGHES, KB
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1984, 98 (07): : 677 - 684
  • [28] GRANULOCYTE PROTEASES IN MIDDLE-EAR EFFUSIONS
    CARLSSON, B
    LUNDBERG, C
    OHLSSON, K
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1982, 91 (01): : 76 - 81
  • [29] MIDDLE-EAR MUCOSA IN CHRONIC EFFUSIONS
    PALVA, T
    MAKINEN, J
    RINNE, J
    ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 1981, 43 (05): : 241 - &
  • [30] THE EFFECTS OF ANESTHESIA ON MIDDLE-EAR EFFUSIONS
    FRIED, MP
    VERNICK, DM
    KELLY, JH
    SILBERSTEIN, V
    STROME, M
    LARYNGOSCOPE, 1988, 98 (01): : 23 - 25